Antimalarial drugs could support existing cancer treatments in two-pronged attack.

Antimalarial drugs could support existing cancer treatments in two-pronged attack. Chloroquine and hydroxychloroquine could make cancer treatments more effective.Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience. Researchers from the Repurposing Drugs in Oncology (ReDO) project, an international collaboration between the Anticancer Fund, Belgium, and USA-based GlobalCures, say there is evidence to include these drugs in further clinical investigations. The authors are particularly excited about the potential for chloroquine and hydroxychloroquine as the evidence suggests they make tumour cells more sensitive to cancer treatment.